Free Trial
The Rate Lock Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 a Year
Claim MarketBeat All Access Sale Promotion

PACS Group (NYSE:PACS) Stock: Insider Michelle Renee Lewis Sells 2,364 Shares

PACS Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Insider sale: PACS Group Chief Accounting Officer Michelle Renee Lewis sold 2,364 shares at an average price of $50.04, totaling $118,294.56, under a pre-arranged Rule 10b5-1 plan. She continues to own 343,510 shares directly and also recently sold 9,464 shares.
  • Stock performance: PACS shares fell 3.9% to $47.76, though the stock remains near its 52-week high of $50.38. The company has a $7.56 billion market capitalization and trades at a P/E ratio of 27.77.
  • Analyst outlook: PACS reported quarterly EPS of $0.63, exceeding expectations of $0.54, while revenue reached $1.43 billion. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $58.80.
  • Five stocks to consider instead of PACS Group.

PACS Group, Inc. (NYSE:PACS - Get Free Report) CAO Michelle Lewis sold 2,364 shares of the firm's stock in a transaction dated Thursday, October 29th. The stock was sold at an average price of $50.04, for a total transaction of $118,294.56. Following the sale, the chief accounting officer directly owned 343,510 shares in the company, valued at $17,189,240.40. This represents a 0.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Michelle Renee Lewis also recently made the following trade(s):

  • On Wednesday, October 28th, Michelle Lewis sold 9,464 shares of PACS Group stock. The shares were sold at an average price of $50.12, for a total transaction of $474,335.68.

PACS Group Trading Down 3.9%

Shares of NYSE:PACS traded down $1.92 during trading on Friday, reaching $47.76. The stock had a trading volume of 591,191 shares, compared to its average volume of 824,846. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21. The stock has a market cap of $7.56 billion, a P/E ratio of 27.77, a PEG ratio of 1.55 and a beta of -0.08. The business has a fifty day moving average price of $44.21 and a 200-day moving average price of $39.79. PACS Group, Inc. has a fifty-two week low of $10.31 and a fifty-two week high of $50.38.

PACS Group (NYSE:PACS - Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.54 by $0.09. The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. As a group, analysts anticipate that PACS Group, Inc. will post 2.13 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

PACS has been the subject of a number of recent analyst reports. Truist Financial set a $62.00 price objective on PACS Group in a research report on Wednesday, September 2nd. Oppenheimer increased their target price on PACS Group from $48.00 to $57.00 and gave the stock an "outperform" rating in a research report on Monday, August 10th. Royal Bank Of Canada raised their price target on PACS Group from $52.00 to $57.00 and gave the stock an "outperform" rating in a research note on Thursday, August 6th. UBS Group lifted their price target on PACS Group from $57.00 to $60.00 and gave the company a "buy" rating in a report on Thursday, August 6th. Finally, Zacks Research downgraded shares of PACS Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, September 9th. Five equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $58.80.

Check Out Our Latest Analysis on PACS Group

Hedge Funds Weigh In On PACS Group

Hedge funds have recently made changes to their positions in the stock. Financial Management Professionals Inc. boosted its holdings in shares of PACS Group by 54.9% in the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company's stock valued at $28,000 after purchasing an additional 235 shares during the last quarter. GK Wealth Management LLC acquired a new stake in shares of PACS Group during the 3rd quarter worth $41,000. USA Financial Formulas acquired a new stake in shares of PACS Group during the 3rd quarter worth $46,000. KBC Group NV purchased a new position in shares of PACS Group in the 1st quarter worth $42,000. Finally, Western Wealth Management LLC purchased a new position in shares of PACS Group in the 1st quarter worth $48,000.

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company's operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.

Read More

Insider Buying and Selling by Quarter for PACS Group (NYSE:PACS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in PACS Group Right Now?

Before you consider PACS Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.

While PACS Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines